Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-27

FDA Approved: HALCION — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for HALCION (triazolam) submitted by Pharmacia & Upjohn Company LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALCION (TRIAZOLAM)

Snippet

SUPPL AP for HALCION (TRIAZOLAM)